Nov 7, 2017 5:00 pm EST Acasti Pharma Announces Dariush Mozaffarian, M.D., Dr.P.H. Principal Investigator for CaPre Phase 3 Development Program
Oct 4, 2017 6:24 pm EDT Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
Aug 16, 2017 11:51 pm EDT Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM
Jul 28, 2017 8:15 am EDT Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures